DK1205190T3 - Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider - Google Patents

Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider

Info

Publication number
DK1205190T3
DK1205190T3 DK00948291T DK00948291T DK1205190T3 DK 1205190 T3 DK1205190 T3 DK 1205190T3 DK 00948291 T DK00948291 T DK 00948291T DK 00948291 T DK00948291 T DK 00948291T DK 1205190 T3 DK1205190 T3 DK 1205190T3
Authority
DK
Denmark
Prior art keywords
drug
stable pharmaceutical
present
pharmaceutical compositions
oral administration
Prior art date
Application number
DK00948291T
Other languages
English (en)
Inventor
Kazuhiro Sako
Toyohiro Sawada
Keiichi Yoshihara
Tatsunobu Yoshioka
Shunsuke Watanabe
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1205190(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK1205190T3 publication Critical patent/DK1205190T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00948291T 1999-08-04 2000-08-01 Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider DK1205190T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04

Publications (1)

Publication Number Publication Date
DK1205190T3 true DK1205190T3 (da) 2006-08-14

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00948291T DK1205190T3 (da) 1999-08-04 2000-08-01 Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider

Country Status (17)

Country Link
EP (1) EP1205190B1 (da)
JP (1) JP3462490B2 (da)
KR (1) KR100507400B1 (da)
CN (1) CN1193792C (da)
AT (1) ATE324909T1 (da)
AU (1) AU769807B2 (da)
CA (1) CA2387705C (da)
DE (1) DE60027728T2 (da)
DK (1) DK1205190T3 (da)
ES (1) ES2262528T3 (da)
HU (1) HU229295B1 (da)
MX (1) MXPA02001267A (da)
NO (1) NO331834B1 (da)
PL (1) PL200645B1 (da)
PT (1) PT1205190E (da)
RU (1) RU2220715C2 (da)
WO (1) WO2001010466A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1662231A (zh) * 2002-04-24 2005-08-31 柏树生物科学公司 包括应激相关障碍在内的功能性躯体障碍的预防与治疗
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
RU2253453C1 (ru) * 2004-03-15 2005-06-10 Общество с ограниченной ответственностью "ЮНАЛ" Противовоспалительная и антиаллергическая композиция
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
RU2279467C1 (ru) * 2005-01-25 2006-07-10 Общество с ограниченной ответственностью "Нурлатский ликеро-водочный завод" Водка "ледок"
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JP2012515757A (ja) * 2009-01-20 2012-07-12 マイクロ ラブス リミテッド トリメタジジンの放出調節固形薬剤組成物及びその製造方法
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
KR101738369B1 (ko) 2009-07-22 2017-05-22 그뤼넨탈 게엠베하 핫 멜트 압출된 제어 방출 투여형
RU2442586C1 (ru) * 2009-11-11 2012-02-20 Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" (НИИ ФХП БГУ) Гидрогелевый противоопухолевый препарат
ES2665467T3 (es) 2010-03-29 2018-04-25 Astellas Pharma Inc. Composición farmacéutica de liberación modificada
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
BR112014001091A2 (pt) 2011-07-29 2017-02-14 Gruenenthal Gmbh comprimido resistente à adulteração que fornece liberação imediata do fármaco
EP2838512B1 (en) 2012-04-18 2018-08-22 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
BR112017019918B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
EP3360866B1 (en) 2017-02-14 2019-01-02 Alfred E. Tiefenbacher (GmbH & Co. KG) Mirabegron prodrugs
BR112021001008A2 (pt) 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
ZA87279B (en) * 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
WO1996032097A1 (fr) * 1995-04-14 1996-10-17 Pharma Pass Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe
RU2092161C1 (ru) * 1995-06-23 1997-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Средство с регулируемым высвобождением пентоксифиллина
JP2001511450A (ja) * 1997-08-01 2001-08-14 エラン コーポレーシヨン ピーエルシー チアガビンを含有する制御放出性の医薬組成物
ATE241341T1 (de) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
KR20020046277A (ko) 2002-06-20
HU229295B1 (en) 2013-10-28
DE60027728T2 (de) 2007-04-26
DE60027728D1 (de) 2006-06-08
RU2220715C2 (ru) 2004-01-10
NO20020516D0 (no) 2002-02-01
KR100507400B1 (ko) 2005-08-10
HUP0202495A3 (en) 2004-05-28
AU769807B2 (en) 2004-02-05
WO2001010466A1 (fr) 2001-02-15
CN1193792C (zh) 2005-03-23
EP1205190B1 (en) 2006-05-03
NO331834B1 (no) 2012-04-16
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
EP1205190A1 (en) 2002-05-15
MXPA02001267A (es) 2002-08-12
AU6182100A (en) 2001-03-05
PT1205190E (pt) 2006-09-29
ATE324909T1 (de) 2006-06-15
JP3462490B2 (ja) 2003-11-05
CA2387705A1 (en) 2001-02-15
CN1373673A (zh) 2002-10-09
NO20020516L (no) 2002-02-01
PL353154A1 (en) 2003-10-20
CA2387705C (en) 2009-06-30
EP1205190A4 (en) 2004-01-21
PL200645B1 (pl) 2009-01-30

Similar Documents

Publication Publication Date Title
DK1205190T3 (da) Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
NO20003196D0 (no) Umiddelbart smeltende doseringsformulering
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
DE69212882D1 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
DE69622510D1 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
DE3750247D1 (de) Methode und Zusammensetzung zur oralen Verabreichung von bioaktiven Mitteln zur Peyer's Flecken.
ATE316375T1 (de) Orale feste zusammensetzung
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
DK0673649T3 (da) Farmaceutiske sammensætninger til forlænget frisætning af trimetazidin efter oral administrering
PT1138333E (pt) Composicao farmaceutica oral
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE60129082D1 (de) Therapeutische Zusammensetzungen welche einen Überschuss eines Amlodipin-Enantiomers enthalten
DK598288D0 (da) Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
DE69406853D1 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69300296D1 (de) Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DK1154776T3 (da) Farmaceutisk sammensætning, indeholdende desoxypeganin til behandling af alkoholisme
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.